The scientists from the USA are actively studying the effect of CBD usage on the medical care of autistic children. Currently, this method has not yet been sufficiently considered, but already has positive reviews. Generally, autism is a group of diseases such as violation of social adaptation speech function, and mental development.
The term “autism” appeared in the United States at the same time as the use of hemp. The first cannabis-based healthcare products aimed for the treatment of children with severe epilepsy in the US. CBD (neuroprotective) enhances brain activity. In a recent study, scientists from Brazil observed the progress of 18 patients for nine months.
The 14 out of 15 patients showed “positive dynamics” in several categories of symptoms. Nine patients who did not have epilepsy or autism showed “dynamics equal to or more than 30%,” and four patients showed significant dynamics in at least four categories, including social interaction and function, and the ability to sleep and stay focused.
Researchers believe the results are promising since enriched CBD can alleviate multiple symptoms (autism spectrum disorders) even in non-epileptic patients. GW Pharmaceuticals, which has patented and sells Epidiolex, medicines for children with epilepsy, is also working on a cannabis-based drug that will be used to treat autism.
“To date, there is limited research, and no evidence, on the potential short-term, long-term or neurodevelopmental risks and benefits of medical marijuana or its related compounds in ASD”Autism Science Foundation
However, not all doctors support this treatment method. In their opinion, there should be more evidence and successful clinical trials, including standardized dosing.
We recall that more states where medical cannabis is legal, including Texas, allow autistic patients to access cannabis oil.